Table 2. hERG1 expression in patient-matched pBE, ED/EA included in the case-control study.
pBE | ED | EA | |
---|---|---|---|
BS1 | + | N/A | + |
BS2 | + | N/A | + |
BS3 | + | + | + |
BS4 | + | N/A | + |
BS5 | + | + | N/A |
BS6 | − | + | N/A |
BS7 | + | N/A | + |
BS8 | + | + | + |
BS9 | − | N/A | + |
BS10 | + | + | + |
FI1 | + | N/A | + |
FI2 | + | N/A | + |
FI3 | + | N/A | + |
FI4 | + | N/A | + |
FI5 | + | N/A | + |
FI6 | + | N/A | + |
SI1 | + | + | N/A |
SI2 | + | + | N/A |
SI3 | − | − | N/A |
SI4 | − | − | − |
SI5 | + | + | + |
SI6 | + | + | N/A |
SI7 | − | + | N/A |
SI8 | + | + | N/A |
SI9 | + | + | N/A |
SI10 | + | + | N/A |
Abbreviations: N/A: histological sample not available for IHC evaluation.